Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J A Walker

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Pharmacology|December 21, 2018
Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivativesMichael K Pugsley, Sandro L Yong, Alan L Goldin, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 26, 2004
Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shieldingAlexander B Zolotoy, Bertrand P Plouvier, Gregory B Beatch, et al.
Proceedings of the Western Pharmacology Society|January 7, 2005
Effects of E4031 and quinidine on atrial and ventricular refractoriness in rabbits in vivoAnnie P K Chan, Monica W L Leung, Petsy P-S So, et al.
Proceedings of the Western Pharmacology Society|January 7, 2005
Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivoMonica W L Leung, Annie P K Chan, Petsy P-S So, et al.
Vascular Pharmacology|September 30, 2022
Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive propertiesElodie Sauge, Dmitri Pechkovsky, N D Prasad Atmuri, et al.
Journal of Medicinal Chemistry|May 18, 2007
Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillationBertrand Plouvier, Gregory N Beatch, Grace L Jung, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trialsLui G Franciosi, Zuzana Diamant, Katharine H Banner, et al.
Pharmacology & Therapeutics|April 17, 2013
The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmiasMichael J Curtis, Jules C Hancox, András Farkas, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Pharmacology|December 21, 2018
Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivativesMichael K Pugsley, Sandro L Yong, Alan L Goldin, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 26, 2004
Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shieldingAlexander B Zolotoy, Bertrand P Plouvier, Gregory B Beatch, et al.
Proceedings of the Western Pharmacology Society|January 7, 2005
Effects of E4031 and quinidine on atrial and ventricular refractoriness in rabbits in vivoAnnie P K Chan, Monica W L Leung, Petsy P-S So, et al.
Proceedings of the Western Pharmacology Society|January 7, 2005
Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivoMonica W L Leung, Annie P K Chan, Petsy P-S So, et al.
Vascular Pharmacology|September 30, 2022
Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive propertiesElodie Sauge, Dmitri Pechkovsky, N D Prasad Atmuri, et al.
Journal of Medicinal Chemistry|May 18, 2007
Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillationBertrand Plouvier, Gregory N Beatch, Grace L Jung, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trialsLui G Franciosi, Zuzana Diamant, Katharine H Banner, et al.
Pharmacology & Therapeutics|April 17, 2013
The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmiasMichael J Curtis, Jules C Hancox, András Farkas, et al.
Pageof 2